JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 16 No. 8 769-774
© 1975 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glaubitt, D. M. H.
Right arrow Articles by Haberland, K. U. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glaubitt, D. M. H.
Right arrow Articles by Haberland, K. U. R.

Bone Marrow Imaging Using 111In-Citrate: 111In-Kinetics in the Pelvic Region

Dieter M. H. Glaubitt, Irmgard H. Schlüter and Klaus U. R. Haberland

Institut für Nuklearmedizin and Medizinische Klinik, Städtische Krankenanstalten, Krefeld, West Germany

Correspondence: For reprints contact: Dieter M. H. Glaubitt, Institut für Nuklearmedizin, Städtische Krankenanstalten Krefeld, D-415 Krefeld, West Germany.

ABSTRACT

When bone marrow scintigraphy was performed using 111In-citrate, radioactivity was observed in the pudendal region. Subsequently, the kinetics of 111In the pelvic region after intravenous administration of 111In-citrate for bone-marrow scanning in 14 patients was examined. On the first day, radioindium was found predominantly in the large pelvic blood vessels and in the pudendal region. In all male patients, the scrotal area was affected with both testes presumably delineated in two patients. In the female patients little radioindium was detected in the pudendal region, most probably in the vulva; distinct radioactivity was found in the pelvis although the ovaries could not be identified. In the following period the 111In uptake in the bone marrow increased considerably and reached its maximum usually 24 hr after the injection. Because a distinct radiation dose from 111In to the gonads cannot be excluded on the basis of our scintigraphic findings and the absorbed dose has not yet been estimated sufficiently, judgment should be used for the present if 111In-citrate is applied for bone marrow imaging.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1975 by the Society of Nuclear Medicine.